Clinical trials
Observational trials in Romania with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Grigore T. Popa University of Medicine and Pharmacy | 9 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 4 |
| University of Medicine and Pharmacy Craiova | 4 |
| Carol Davila University of Medicine and Pharmacy | 3 |
| Anemia Working Group Romania | 2 |
| Cardio Med Medical Center | 2 |
| Clinical Hospital Colentina | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Asociatia Oncohelp - Centrul de Oncologie Oncohelp | 1 |
| Calla IVF Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 5 |
| Fibrosis | 4 |
| Aortic Valve Stenosis | 3 |
| Cardiovascular Diseases | 3 |
| Atherosclerosis | 2 |
| Cognitive Dysfunction | 2 |
| Coronary Artery Disease | 2 |
| Inflammatory Bowel Diseases | 2 |
| Malnutrition | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.